Posts tagged as

David Fuller

David Fuller & Barbara Smith Featured in JNP Podcasts

Drs. David Fuller and Barbara Smith, BREATHE Steering Committee members, were recently featured on the Journal of Neurophysiology Podcast. They met with Editor-in-Chief Dr. Nino Ramirez to discuss their most recent publication, “Case Studies in Neuroscience:…

MBI Rising Stars: Dr. Sabhya Rana

Sabhya Rana, Ph.D., a postdoctoral associate in the department of physical therapy, is the latest investigator to be featured in MBI Rising Stars, a video series highlighting up-and-coming neuroscience researchers at the University of Florida.

BREATHE Members & Trainees Receive APS Awards at EB 2021

Experimental Biology (EB) is the annual meeting of five societies that explores the latest research in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. This international meeting is the highlight of the year for many BREATHE researchers and, despite being virtual this year, EB2021 was no exception. During…

EB Special Techniques Workshop

Join BREATHE member, Dr. David Fuller, and friend of the center, Dr. Melissa Bates, on April 22nd from 11am-1pm ET at an upcoming techniques workshop program entitled: “Current approaches for measuring respiratory activity in animals: recognizing and avoiding common pitfalls.” This workshop will be held outside the EB 2021 virtual meeting platform and will be…

Fuller and Smuder Awarded NIH R01 for Hyperbaric Oxygen Therapy

Drs. Dave Fuller and Ashley Smuder were recently awarded an NIH R01 grant to study the impact of hyperbaric oxygen therapy (HBO) on respiratory neuromuscular recovery after spinal cord injury.  They will investigate their hypothesis that HBO, delivered in the acute phases after cervical spinal cord…

Fuller and Byrne Awarded NIH R01 for Pompe Disease

Dave Fuller, Professor of Physical Therapy and BREATHE Associate Director, and Barry Byrne, Associate Chair of Pediatrics, Director of the Powell Gene Therapy Center, and BREATHE member, received a 5-year NIH R01 award to continue their work on gene therapy for …